Provided by Tiger Trade Technology Pte. Ltd.

Liquidia Technologies Inc

27.99
-2.2700-7.50%
Pre-market: 26.83-1.1600-4.14%09:17 EDT
Volume:21.57M
Turnover:560.80M
Market Cap:2.51B
PE:19.99
High:28.10
Open:23.96
Low:22.31
Close:30.26
52wk High:93.61
52wk Low:21.35
Shares:89.51M
Float Shares:70.89M
Volume Ratio:3.90
T/O Rate:30.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.40
EPS(LYR):-0.8009
ROE:131.82%
ROA:27.04%
PB:12.84
PE(LYR):-34.95

Loading ...

Liquidia Corporation - District Court Rules Two Claims Against Liquidia Valid and Infringed

THOMSON REUTERS
·
Yesterday

Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent

THOMSON REUTERS
·
Yesterday

Liquidia Corporation - Uthr Requests Injunctive Relief to Restrict Yutrepia Market Availability

THOMSON REUTERS
·
Yesterday

Liquidia Corporation: "Respectfully Disagree with Court's Decision Regarding Claims 1 and 14"

THOMSON REUTERS
·
Yesterday

Liquidia Corporation - Parties to Submit Form of Judgment Specifying Remedy Within One Week

THOMSON REUTERS
·
Yesterday

Liquidia ruling has positive read-through for MannKind Tyvaso DPI, says Truist

TIPRANKS
·
Yesterday

United Therapeutics Gets Legal Win in Patent Litigation Against Liquidia

Dow Jones
·
Yesterday

Judge upholds claims 1, 14 of United Therapeutics’ ‘327 patent

TIPRANKS
·
Yesterday

United Therapeutics up 13% to $543.85 following Liquidia patent ruling

TIPRANKS
·
Yesterday

Liquidia drops 23% in late morning trading

TIPRANKS
·
Sep 30

Liquidia Technologies trading resumes

TIPRANKS
·
Sep 30

NASDAQ Trade Halt Volatility Trading Pause at 11:24 Am

Reuters
·
Sep 30

Liquidia Technologies put volume heavy and directionally bearish

TIPRANKS
·
Sep 22

Bellevue Flags US Healthcare Innovation as Driving Fresh Investment Opportunities

Reuters
·
Sep 14

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Surrozen (SRZN), Liquidia Technologies (LQDA) and Universal Health (UHS)

TIPRANKS
·
Sep 09

Liquidia granted Fast Track designation to Yutrepia inhalation powder

TIPRANKS
·
Sep 03

Liquidia Corporation - FDA Grants Fast Track Designation to Yutrepia for Ssc-Rp

THOMSON REUTERS
·
Sep 03

Liquidia Corporation - Re-Warm Study Expected to Begin October 2026 with Primary Completion February 2027

THOMSON REUTERS
·
Sep 03

Liquidia Corporation - to Initiate Re-Warm Phase 2a Study of Yutrepia in Ssc-Rp in Q4 2026

THOMSON REUTERS
·
Sep 03

Wells Fargo Sticks to Their Buy Rating for Liquidia Technologies (LQDA)

TIPRANKS
·
Sep 02